Balance Sheet - Tango Therapeutics, Inc. (TNGX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 343.14 | 257.92 | 336.89 | 366.13 | 485.26 | 190.32 | 40.43 |
| Accounts receivable, net | 0.00 | 2.00 | 2.00 | 2.00 | |||
| Inventories | 0.57 | 0.57 | |||||
| Other current assets | 10.62 | 8.43 | 9.65 | 7.14 | 5.08 | 1.31 | 1.23 |
| Total current assets | 353.76 | 266.34 | 346.54 | 375.27 | 492.34 | 193.63 | 41.66 |
| Total non-current assets | 44.93 | 50.15 | 56.03 | 61.20 | 7.82 | 13.62 | 14.11 |
| Total assets | 398.69 | 316.49 | 402.57 | 436.47 | 500.16 | 207.25 | 55.76 |
| Total current liabilities | 21.68 | 38.17 | 45.94 | 55.55 | 40.69 | 40.92 | 25.85 |
| Total non-current liabilities | 30.83 | 78.81 | 103.52 | 131.45 | 114.72 | 127.74 | 22.01 |
| Total liabilities | 52.51 | 116.98 | 149.46 | 186.99 | 155.41 | 168.65 | 47.86 |
| Total stockholders' equity | 346.18 | 199.52 | 253.11 | 249.48 | 344.75 | 38.60 | 7.91 |
| Common shares outstanding | 116 | 109 | 95 | 88 | 62 | 87 | 87 |
Show Quarterly Balance Sheet
Balance Sheet - Tango Therapeutics, Inc. (TNGX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 379.84 | 343.14 | 152.81 | 180.79 | 216.72 | 257.92 | 293.28 | 322.11 | 343.60 | 336.89 | 359.88 | 310.65 | 333.64 | 366.13 | 393.29 | 416.36 | 449.89 | 485.26 | 503.81 | 198.35 | 206.91 | 190.32 | 168.31 | 0.02 | 40.43 |
| Accounts receivable, net | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 8.00 | 2.00 | 2.00 | 2.00 | ||||||||||||
| Inventories | 0.57 | 0.00 | 0.00 | 0.57 | 0.00 | 0.00 | |||||||||||||||||||
| Other current assets | 12.49 | 10.62 | 10.97 | 9.32 | 8.21 | 8.43 | 7.54 | 6.30 | 8.44 | 9.65 | 11.01 | 9.89 | 9.36 | 7.14 | 6.38 | 17.73 | 8.77 | 5.08 | 4.53 | 1.71 | 1.45 | 1.31 | 0.07 | ||
| Total current assets | 392.33 | 353.76 | 163.78 | 190.10 | 224.93 | 266.34 | 300.82 | 328.41 | 352.04 | 346.54 | 370.89 | 320.54 | 343.00 | 375.27 | 401.67 | 436.09 | 460.65 | 492.34 | 516.34 | 202.06 | 210.36 | 193.63 | 1.62 | 0.02 | 40.43 |
| Total non-current assets | 43.47 | 44.93 | 46.36 | 47.79 | 49.38 | 50.15 | 51.60 | 53.04 | 54.19 | 56.03 | 57.30 | 58.79 | 60.77 | 61.20 | 62.48 | 12.31 | 10.87 | 7.82 | 13.80 | 15.18 | 13.76 | 13.62 | 166.76 | 0.04 | -40.43 |
| Total assets | 435.79 | 398.69 | 210.14 | 237.89 | 274.31 | 316.49 | 352.42 | 381.45 | 406.22 | 402.57 | 428.19 | 379.33 | 403.77 | 436.47 | 464.16 | 448.40 | 471.53 | 500.16 | 530.14 | 217.24 | 224.11 | 207.25 | 168.38 | 0.06 | |
| Total current liabilities | 14.33 | 21.68 | 18.44 | 40.03 | 35.92 | 38.17 | 37.58 | 43.87 | 42.79 | 45.94 | 43.42 | 53.63 | 53.67 | 55.55 | 51.32 | 44.68 | 39.21 | 40.69 | 41.99 | 37.22 | 36.85 | 40.92 | 0.12 | 0.04 | |
| Total non-current liabilities | 29.96 | 30.83 | 31.66 | 62.91 | 71.63 | 78.81 | 85.66 | 89.91 | 98.98 | 103.52 | 108.18 | 112.75 | 122.84 | 131.45 | 139.76 | 105.01 | 111.96 | 114.72 | 122.74 | 125.13 | 129.37 | 127.74 | 5.84 | ||
| Total liabilities | 44.29 | 52.51 | 50.11 | 102.94 | 107.55 | 116.98 | 123.25 | 133.78 | 141.77 | 149.46 | 151.59 | 166.38 | 176.51 | 186.99 | 191.08 | 149.70 | 151.17 | 155.41 | 164.72 | 162.35 | 166.22 | 168.65 | 5.95 | 0.04 | |
| Total stockholders' equity | 391.51 | 346.18 | 160.03 | 134.95 | 166.76 | 199.52 | 229.17 | 247.67 | 264.45 | 253.11 | 276.60 | 212.95 | 227.26 | 249.48 | 273.07 | 298.70 | 320.36 | 344.75 | 365.41 | 54.89 | 57.89 | 38.60 | 162.43 | 0.02 | 7.91 |
| Common shares outstanding | 144 | 116 | 111 | 111 | 110 | 109 | 109 | 108 | 108 | 96 | 97 | 88 | 88 | 88 | 88 | 88 | 88 | 88 | 70 | 87 | 87 | 87 | 87 | 87 | 87 |